Is ImmunoPrecise Antibodies Ltd. (IPA) a Buy, Sell, or Hold?
NASDAQ : IPA
ImmunoPrecise Antibodies Ltd. — News
$1.62 USD
$0.04 (2.53%)
- Volume
- 55.66K
- Average Volume
- 2.91M
- Market Capitalization
- $74.77M
- P/E Ratio
- -8.07
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.25
- Year Low
- $0.27
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.74
| Source | Headline |
|---|---|
|
The Biology Came First.
MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in a gurufocus.com - 2026-05-18 09:00:00 |
|
Atlas AI Labs to Launch First Ever Permissionless Asset-Backed Token from Dubai
Atlas AI Labs to Launch First Ever Permissionless Asset-Backed Token from Dubai PR Newswire DUBAI, UAE, May 12, gurufocus.com - 2026-05-12 09:34:00 |
|
Blue Point Brewing Launches Magic Hour IPA—A Bright, Tropical 6% ABV Sipper for Golden Hour
PATCHOGUE, N.Y., May 12, 2026 (GLOBE NEWSWIRE) -- Blue Point Brewing, a Long Island craft brewery and brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is launching a new year-round offering, Magic Hour IPA. globenewswire.com - 2026-05-12 07:00:00 |
